A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults

<p>Background: Adjunctive dexamethasone reduces mortality from tuberculous meningitis (TBM) but not disability, which is associated with brain infarction. We hypothesised that aspirin prevents TBM-related brain infarction through its anti-thrombotic, anti-inflammatory, and pro-resolution prope...

Full description

Bibliographic Details
Main Authors:	Mai, N, Day, J, Dobbs, N, Phu, N, Colas, R, Thao, L, Thuong, N, Nghia, H, Hanh, N, Hang, N, Heemskerk, A, Ly, L, Thu, D, Thwaites, G, Kestelyn, E, Merson, L, Wolbers, M, Geskus, G, Dalli, J, Summers, D
Format:	Journal article
Published:	eLife Sciences Publications 2018

Similar Items

Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial
by: Donovan, J, et al.
Published: (2018)

Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adult
by: Donovan, J, et al.
Published: (2023)

Prognostic models for 9 month mortality in tuberculous meningitis.
by: Thao, L, et al.
Published: (2017)

Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis
by: Nhu, N, et al.
Published: (2014)

Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.
by: Nhu, N, et al.
Published: (2014)

Intensified antituberculosis therapy in adults with tuberculous meningitis
by: Heemskerk, AD, et al.
Published: (2016)

Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis
by: Donovan, J, et al.
Published: (2020)

Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial
by: Donovan, J, et al.
Published: (2018)

Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
by: Colas, RA, et al.
Published: (2019)

Therapy for tuberculous meningitis
by: Heemskerk, A, et al.
Published: (2016)

Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
by: Thuong, N, et al.
Published: (2017)

Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements
by: Thao, L, et al.
Published: (2019)

Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis
by: Mai, N, et al.
Published: (2009)

Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis.
by: Mai, N, et al.
Published: (2009)

Human genetic susceptibility to tuberculous meningitis in Vietnamese population
by: Thuong, N, et al.
Published: (2010)

Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
by: Heemskerk, D, et al.
Published: (2011)

Influence of Strongyloides stercoralis coinfection on the presentation, pathogenesis, and outcome of tuberculous meningitis
by: Donovan, J, et al.
Published: (2020)

Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study
by: Bang, N, et al.
Published: (2016)

Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis
by: Ding, J, et al.
Published: (2020)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
by: Simmons, C, et al.
Published: (2005)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
by: Simmons, C, et al.
Published: (2005)

The neurocritical care of tuberculous meningitis
by: Donovan, J, et al.
Published: (2019)

A novel diagnostic model for tuberculous meningitis using Bayesian latent class analysis
by: Dong, THK, et al.
Published: (2024)

A statistical analysis plan for the Adjunctive Corticosteroids for Tuberculous meningitis in HIV-positive adults (ACT HIV) clinical trial
by: Donovan, J, et al.
Published: (2021)

Tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2000)

Adjunctive dexamethasone in HIV-associated cryptococcal meningitis
by: Beardsley, J, et al.
Published: (2016)

Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis
by: Hai, HT, et al.
Published: (2024)

Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis.
by: Wolbers, M, et al.
Published: (2011)

Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2003)

Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis
by: Thwaites, G, et al.
Published: (2003)

Tuberculous meningitis: reducing the burden of disease by improving diagnosis and treatment
by: Heemskerk, A
Published: (2016)

Prediction models for mortality in tuberculous meningitis
by: Le Thi Phuong Thao
Published: (2019)

Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features.
by: Thwaites, G, et al.
Published: (2002)

Comparative Genomics of Cryptococcus neoformans var. grubii Associated with Meningitis in HIV Infected and Uninfected Patients in Vietnam
by: Day, J, et al.
Published: (2017)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
by: Török, M, et al.
Published: (2011)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis
by: Török, M, et al.
Published: (2011)

Validation of a diagnostic algorithm for adult tuberculous meningitis.
by: Török, M, et al.
Published: (2007)

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen
by: Heemskerk, A, et al.
Published: (2017)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
by: Donovan, J, et al.
Published: (2020)

Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.
by: Tho, D, et al.
Published: (2012)